NOVEL PIPERAZINYL-PYRAZINONE DERIVATIVES FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISORDERS

摘要

COMPOUNDS OF THE GENERAL FORMULA (I) : WHEREIN M, N, R1, R2, R3, AND R4 ARE AS DESCRIBED IN THE SPECIFICATION. FURTHER INCLUDED ARE PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS, PROCESSES FOR THEIR PREPARATION, AS WELL AS THE USE OF THE COMPOUNDS FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF 5-HT2A RECEPTOR-RELATED DISORDERS OR MEDICAL CONDITIONS.